Jan 03, 08
|
| NEW STORY |
| 08:00 ET |
Dawson James Securities Initiates Research Coverage on NovaBay Pharmaceuticals (Amex: NBY) With a Speculative Buy Rating -- 12-18 Month Target Price $8.00
|
|
Aug 29, 07
|
| 08:00 ET |
Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
|
|
Jul 12, 07
|
| 07:30 ET |
Dawson James Securities Initiates Research Coverage on A.P. Pharma, Inc. (Nasdaq: APPA) with a Speculative Buy Rating - 12-18 Month Target Price $4.50
|
|
May 22, 07
|
| 12:30 ET |
Dawson James Securities Reiterates Speculative Buy Recommendation on Biopure Corp. (Nasdaq: BPUR) with $3.00 Price Target.
|
|
May 11, 07
|
| 13:25 ET |
Dawson James Securities Reiterates Speculative Buy Recommendation on iCAD, Inc. (Nasdaq: ICAD) with $5.00 Price Target
|
|
May 02, 07
|
| 11:06 ET |
Dawson James Securities Initiates Research Coverage on TranSwitch Corp. (Nasdaq: TXCC) with a Speculative Buy Rating - 12-18 Month Target Price $2.50
|
|
Apr 02, 07
|
| 13:09 ET |
Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price Target
|
|
Jan 30, 07
|
| 08:30 ET |
Dawson James Securities Initiates Research Coverage on Neurobiological Technologies, Inc. (Nasdaq: NTII) with a Speculative Buy Rating -- 12-18 Month Target Price $7.00
|
|
Jan 04, 07
|
| 17:03 ET |
Dawson James Securities Discusses 2007 Outlook for Biopure and Viragen
|
|
Mar 16, 06
|
| 08:00 ET |
Dawson James Securities Upgrades Antares Pharma to Strong Buy With $4.00 Price Target
|
|
|